Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Capital Expenditures: 2013-2025

Historic Capital Expenditures for MediWound (MDWD) over the last 13 years, with Sep 2025 value amounting to -$1.0 million.

  • MediWound's Capital Expenditures rose 12.33% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 65.40%. This contributed to the annual value of $6.3 million for FY2024, which is 2.95% down from last year.
  • MediWound's Capital Expenditures amounted to -$1.0 million in Q3 2025, which was up 0.38% from -$1.0 million recorded in Q2 2025.
  • MediWound's 5-year Capital Expenditures high stood at $11.7 million for Q4 2024, and its period low was -$3.0 million during Q2 2024.
  • Its 3-year average for Capital Expenditures is $880,364, with a median of -$1.1 million in 2023.
  • The largest annual percentage gain for MediWound's Capital Expenditures in the last 5 years was 1,045.19% (2023), contrasted with its biggest fall of 1,930.12% (2023).
  • MediWound's Capital Expenditures (Quarterly) stood at -$116,000 in 2021, then surged by 906.90% to $936,000 in 2022, then surged by 1,045.19% to $10.7 million in 2023, then rose by 9.53% to $11.7 million in 2024, then climbed by 12.33% to -$1.0 million in 2025.
  • Its Capital Expenditures was -$1.0 million in Q3 2025, compared to -$1.0 million in Q2 2025 and -$959,000 in Q1 2025.